FindTrial
Sign In

Analysis of the influence of Helicobacter pylori on Parkinson's constipation patients through intestinal microbiome

Analysis of the influence of Helicobacter pylori on Parkinson's constipation patients through intestinal microbiome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071631
Enrollment
Unknown
Registered
2023-05-19
Start date
2023-05-31
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's constipation

Interventions

HP positive PD constipation group (E group):None
Hp-negative PD constipation group (Group F):None
Health group (Group C):None

Sponsors

Xuanwu Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ? Meeting the diagnostic criteria of Parkinson's disease; ? Normal cognitive function; ? He has not received mutilation or deep brain stimulation. ? It meets the diagnostic criteria of Rome IV functional constipation.

Exclusion criteria

Exclusion criteria: Exclusion criteria: ? serious cardiovascular and cerebrovascular diseases; ? primary organic diseases of gastrointestinal tract; ? Secondary PD; ? Parkinson's superimposed syndrome; (5) Mental illness, serious physical disease; Nearly 12 weeks since taking gastrointestinal function regulation drugs.

Design outcomes

Primary

MeasureTime frame
Intestinal flora diversity;—

Countries

China

Contacts

Public ContactChen Biao

Xuanwu Hospital of Capital Medical University

linethree@sina.com+86 10 8319 8872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026